Alexander Knuth
Corporate Officer/Principal bij University of Zurich
Profiel
Alexander Knuth was the founder and former Chairman of CT Atlantic Ltd.
which was founded in 2008.
He is currently the Director of the Oncology Department at the University of Zurich.
Dr. Knuth's former positions include being a Professor at Klinikum Eilbek and Johann Wolfgang Goethe-Universität Frankfurt am Main, as well as being a Principal at Ludwig Institute for Cancer Research Ltd.
Actieve functies van Alexander Knuth
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Zurich | Corporate Officer/Principal | 17-09-2009 |
Eerdere bekende functies van Alexander Knuth
| Bedrijven | Functie | Einde |
|---|---|---|
Klinikum Eilbek
 Klinikum Eilbek Hospital/Nursing ManagementHealth Services Part of Schön Klinik SE, Klinikum Eilbek operates a hospital. The company is based in Hamburg, Germany. Klinikum Eilbek was acquired by Schön Klinik Verwaltung GmbH from Broermann Holding GmbH on August 02, 2006. | Corporate Officer/Principal | - |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Corporate Officer/Principal | - |
Ludwig Institute for Cancer Research Ltd.
 Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
CT Atlantic Ltd.
 CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services CT Atlantic AG focuses on the identification and development of human-derived monoclonal antibodies as novel therapeutics for the treatment of cancer. The company was founded by Alexander Knuth, Christoph Esslinger and Edward Stuart in 2008 and is headquartered in Schlieren, Switzerland. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
CT Atlantic Ltd.
CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services CT Atlantic AG focuses on the identification and development of human-derived monoclonal antibodies as novel therapeutics for the treatment of cancer. The company was founded by Alexander Knuth, Christoph Esslinger and Edward Stuart in 2008 and is headquartered in Schlieren, Switzerland. | Commercial Services |
Ludwig Institute for Cancer Research Ltd.
Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Health Services |
Klinikum Eilbek
Klinikum Eilbek Hospital/Nursing ManagementHealth Services Part of Schön Klinik SE, Klinikum Eilbek operates a hospital. The company is based in Hamburg, Germany. Klinikum Eilbek was acquired by Schön Klinik Verwaltung GmbH from Broermann Holding GmbH on August 02, 2006. | Health Services |
